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Ethyl 5-[2,4-bis(methoxymethoxy)-6-(4-nitrophenoxy)phenyl]-2,4-dioxobutanoate (4). To a stirred solution of sodium tert-butoxide (0.284 g, 2.51 mmol) in THF (8 mL) at -10 °C, was added diethyl oxalate (0.5 mL, 3.42 mmol) in 2 mL of precooled THF. After 30 min a solution of (3) (430 mg, 1.14 mmol) in THF (4 mL) was added drop wise. The reaction mixture was stirred for 1 h at -10 °C and then further 16 h at room temperature. The solution was poured into a 10% citric acid solution (30 mL) and thoroughly extracted with EtOAc. After washing with brine and drying over MgSO4, the combined organic fractions were evaporated to provide a yellow crude residue.
Purification using column chromatography yielded (4). (Yield: 98%, proceeded to the next step without further characterization)
Ethyl 5-[2,4-bis(methoxymethoxy)-6-(4-nitrophenoxy)phenyl]-isoxazole-3-carboxylate (5).
To a stirred solution of (4) (0. 42 g, 0.88 mmol) in EtOH (12 mL), hydroxylamine hydrochloride (2.67 mg, 4.02 mmol) was added. After stirring for 3 h at 60 °C, the solvent was evaporated, saturated NaHCO3 (30 mL) was added and the suspension was taken up in DCM (30 mL) and thoroughly washed with water and dried over MgSO4. The solvent was removed by evaporation and purification using column chromatography was performed to afford (5 6, 62.3, 100.6, 101.2, 104.7, 117.2, 120.1, 126.2, 143.4, 154.8, 156.4, 159.2, 160.7, 162.2, 163.7, 167.4 20.2, 28.0, 31.6, 80.5, 100.7, 100.9, 101.2, 103.7, 117.1, 126.2, 143.3, 154.7, 155.7, 158.7, 159.1, 160.3, 162.0, 163.8, 166.8, 172.3 . HRMS (ESI) calculated for C26H29N4O9
Tert-butyl-4-[({5-[2,4-bis(methoxymethoxy)-6-(4-nitrophenoxy)phenyl]-isoxazole-3-
[M+H] + : 541.1929 541. . Found: 541.1914 .
5-[2,4-Dihydroxy-6-(4-nitrophenoxy) phenyl]-N-(piperidin-4-yl)-isoxazole-3-carboxamide
(7). To a stirred solution of (6) (50 mg) in DCM (5 mL) was added TFA (3 eq), the reaction mixture was stirred for 16 h and monitored by LC-MS. After completion, the reaction mixture was diluted with DCM (10 mL) and washed with 0.1 M NaOH and saturated NaHCO3. Purification over a short pad of silica gel yielded (7 Plasma radiometabolite study and biodistribution studies Table S1 . Gradient mixture and flow rate used at given time points for radiometabolite study of Table S4 . Biodistribution data of [ 11 C]NMS-E973 in male NMRI-mice pretreated with vehicle, NMS-E973 (25mg/kg) or PU-H71 (50 mg/kg) at 10 min after tracer injection. Table S5 . Biodistribution data of [ 11 C]NMS-E973 in B16.F10 melanoma inoculated C57BL/6 mice at 60 min after tracer injection with pretreatment of vehicle, PU-H71 or Ganetespib. Figure S8 . RadioHPLC analysis of plasma samples (radiometabolite study). Polar radiometabolite fractions for respectively 2, 10 and 30 min account for 11 ± 4%, 25 ± 6% and 28 ± 8% of total plasma activity.
